Bio-Rad Laboratories (BIO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Bio-Rad Laboratories Revenue Highlights

Latest Revenue (Y)

$2.67T

Latest Revenue (Q)

$649.73M

Main Segment (Y)

Clinical Diagnostics

Main Geography (Y)

UNITED STATES

Bio-Rad Laboratories Revenue by Period

Bio-Rad Laboratories Revenue by Year

Date	Revenue	Change
2023-12-31	$2.67T	95225.65%
2022-12-31	$2.80B	-4.12%
2021-12-31	$2.92B	14.81%
2020-12-31	$2.55B	10.12%
2019-12-31	$2.31B	0.94%
2018-12-31	$2.29B	6.02%
2017-12-31	$2.16B	4.45%
2016-12-31	$2.07B	2.41%
2015-12-31	$2.02B	-7.15%
2014-12-31	$2.18B	1.99%
2013-12-31	$2.13B	3.07%
2012-12-31	$2.07B	-0.21%
2011-12-31	$2.07B	7.60%
2010-12-31	$1.93B	8.01%
2009-12-31	$1.78B	1.13%
2008-12-31	$1.76B	20.76%
2007-12-31	$1.46B	14.69%
2006-12-31	$1.27B	7.87%
2005-12-31	$1.18B	8.35%
2004-12-31	$1.09B	8.63%
2003-12-31	$1.00B	12.40%
2002-12-31	$892.72M	9.20%
2001-12-31	$817.51M	12.62%
2000-12-31	$725.88M	32.10%
1999-12-31	$549.50M	24.35%
1998-12-31	$441.90M	3.51%
1997-12-31	$426.90M	1.93%
1996-12-31	$418.80M	5.60%
1995-12-31	$396.60M	11.62%
1994-12-31	$355.30M	8.13%
1993-12-31	$328.60M	-

Bio-Rad Laboratories generated $2.67T in revenue during NA 2023, up 95225.65% compared to the previous quarter, and up 116643.44% compared to the same period a year ago.

Bio-Rad Laboratories Revenue by Quarter

Date	Revenue	Change
2024-09-30	$649.73M	1.76%
2024-06-30	$638.48M	4.53%
2024-03-31	$610.82M	-10.33%
2023-12-31	$681.18M	7.76%
2023-09-30	$632.12M	-7.19%
2023-06-30	$681.11M	0.63%
2023-03-31	$676.84M	-7.32%
2022-12-31	$730.29M	7.27%
2022-09-30	$680.80M	-1.49%
2022-06-30	$691.10M	-1.28%
2022-03-31	$700.06M	-4.46%
2021-12-31	$732.77M	-1.91%
2021-09-30	$747.05M	4.35%
2021-06-30	$715.93M	-1.49%
2021-03-31	$726.80M	-7.98%
2020-12-31	$789.84M	22.03%
2020-09-30	$647.26M	20.56%
2020-06-30	$536.88M	-6.08%
2020-03-31	$571.64M	-8.45%
2019-12-31	$624.43M	11.38%
2019-09-30	$560.63M	-2.09%
2019-06-30	$572.62M	3.36%
2019-03-31	$553.98M	-10.29%
2018-12-31	$617.54M	13.28%
2018-09-30	$545.14M	-5.34%
2018-06-30	$575.91M	4.42%
2018-03-31	$551.52M	-11.11%
2017-12-31	$620.43M	15.97%
2017-09-30	$535.00M	6.01%
2017-06-30	$504.67M	0.92%
2017-03-31	$500.05M	-12.49%
2016-12-31	$571.45M	12.33%
2016-09-30	$508.75M	-1.55%
2016-06-30	$516.78M	9.67%
2016-03-31	$471.20M	-17.41%
2015-12-31	$570.56M	21.41%
2015-09-30	$469.96M	-7.14%
2015-06-30	$506.10M	7.04%
2015-03-31	$472.82M	-20.96%
2014-12-31	$598.22M	12.74%
2014-09-30	$530.64M	-1.15%
2014-06-30	$536.83M	5.40%
2014-03-31	$509.34M	-15.48%
2013-12-31	$602.63M	19.32%
2013-09-30	$505.07M	-3.86%
2013-06-30	$525.32M	5.13%
2013-03-31	$499.67M	-12.92%
2012-12-31	$573.84M	15.07%
2012-09-30	$498.70M	-2.30%
2012-06-30	$510.42M	4.97%
2012-03-31	$486.28M	-11.62%
2011-12-31	$550.24M	6.53%
2011-09-30	$516.51M	-0.99%
2011-06-30	$521.66M	7.53%
2011-03-31	$485.12M	-9.11%
2010-12-31	$533.72M	13.20%
2010-09-30	$471.50M	0.82%
2010-06-30	$467.66M	2.96%
2010-03-31	$454.23M	-8.25%
2009-12-31	$495.07M	7.38%
2009-09-30	$461.06M	7.93%
2009-06-30	$427.18M	6.55%
2009-03-31	$400.93M	-10.50%
2008-12-31	$447.96M	1.39%
2008-09-30	$441.84M	-2.33%
2008-06-30	$452.36M	7.14%
2008-03-31	$422.20M	-8.16%
2007-12-31	$459.69M	-

Bio-Rad Laboratories generated $649.73M in revenue during Q3 2024, up 1.76% compared to the previous quarter, and up 95.39% compared to the same period a year ago.

Bio-Rad Laboratories Revenue Breakdown

Bio-Rad Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Life Science	$1.18B	$1.35B	$1.40B	$1.23B	$885.90M
Clinical Diagnostics	$1.49B	$1.45B	$1.52B	$1.31B	$1.41B
Other Segments	$3.60M	$4.00M	$5.80M	$8.60M	$13.80M

Bio-Rad Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 23: Clinical Diagnostics (55.75%), Life Science (44.11%), and Other Segments (0.13%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Clinical Diagnostics	$388.80M	$368.60M	$389.00M	$368.10M	$380.10M	$352.10M	$369.60M	$361.90M	$367.80M	$351.80M	$404.90M	$372.20M	$380.20M	$358.50M	$359.60M	$322.20M	$283.20M	$340.30M	$379.10M	$341.80M
Life Science	$260.90M	$241.70M	$291.10M	$263.50M	$300.20M	$323.60M	$359.70M	$317.90M	$322.40M	$347.20M	$326.60M	$373.50M	$334.20M	$366.50M	$428.60M	$324.00M	$252.10M	$227.20M	$242.00M	$215.70M
Other Segments	-	$500.00K	$1.20M	$500.00K	$800.00K	$1.10M	$900.00K	$1.00M	$900.00K	$1.10M	$1.20M	$1.30M	$1.50M	$1.80M	$1.60M	$1.10M	$1.60M	$4.10M	$3.40M	$3.10M

Bio-Rad Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Clinical Diagnostics (59.84%), and Life Science (40.16%).

Bio-Rad Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
UNITED STATES	$1.12B	$1.16B	$1.13B	$1.00B	$899.10M
Americas	$166.60M	$155.40M	$156.60M	$136.60M	$137.30M
Asia Pacific	$563.00M	$639.40M	$688.40M	$546.50M	$505.00M
Europe	$819.80M	$851.90M	$946.90M	$857.70M	$770.30M

Bio-Rad Laboratories's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (42.00%), Europe (30.69%), Asia Pacific (21.08%), and Americas (6.24%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Europe	$205.70M	$200.20M	$210.70M	$193.10M	$211.20M	$204.80M	$215.60M	$200.10M	$217.30M	$218.90M	$248.70M	$221.50M	$229.10M	$247.70M	$267.10M	$220.90M	$174.00M	$195.70M	$214.20M	$181.90M
Americas	$40.90M	$40.50M	$43.50M	$44.70M	$39.20M	$39.20M	$38.20M	$39.80M	$39.50M	$37.80M	$38.60M	$38.90M	$40.10M	$38.80M	$39.10M	$34.00M	$28.50M	$35.00M	$34.50M	$32.20M
Asia Pacific	$126.90M	$117.20M	$165.30M	$118.90M	$143.00M	$135.80M	$169.10M	$156.80M	$152.70M	$160.90M	$176.20M	$171.20M	$172.10M	$168.90M	$164.20M	$142.00M	$129.00M	$111.40M	$150.70M	$120.70M
UNITED STATES	$276.20M	$252.90M	$261.80M	$275.40M	$287.70M	$297.00M	$307.30M	$284.10M	$281.60M	$282.50M	$269.20M	$315.40M	$274.60M	$271.40M	$319.40M	$250.40M	$205.40M	$229.50M	$225.10M	$225.80M

Bio-Rad Laboratories's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (42.51%), Europe (31.66%), Asia Pacific (19.53%), and Americas (6.30%).

Bio-Rad Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BIO	Bio-Rad Laboratories	$2.67T	$649.73M
STE	STERIS	$5.14B	$1.33B
DXCM	DexCom	$3.62B	$994.20M
BRKR	Bruker	$2.96B	$800.70M
ZBH	Zimmer Biomet	$1.94B	$143.40M
PODD	Insulet	$1.70B	$372.60M
ITGR	Integer	$1.60B	$746.27M
GMED	Globus Medical	$1.57B	$625.71M
CNMD	CONMED	$1.24B	$316.70M
PEN	Penumbra	$1.06B	$301.04M
TNDM	Tandem Diabetes Care	$747.72M	$221.91M
INSP	Inspire Medical Systems	$624.80M	$203.19M
NVCR	NovoCure	$509.34M	$155.09M
NARI	Inari Medical	$493.63M	$153.39M
GKOS	Glaukos	$314.71M	$96.67M
ANIK	Anika Therapeutics	$166.66M	$38.75M

BIO Revenue FAQ

What is Bio-Rad Laboratories’s yearly revenue?

Bio-Rad Laboratories's yearly revenue for 2023 was $2.67T, representing an increase of 95225.65% compared to 2022. The company's yearly revenue for 2022 was $2.8B, representing a decrease of -4.12% compared to 2021. BIO's yearly revenue for 2021 was $2.92B, representing an increase of 14.81% compared to 2020.

What is Bio-Rad Laboratories’s quarterly revenue?

Bio-Rad Laboratories's quarterly revenue for Q3 2024 was $649.73M, a 1.76% increase from the previous quarter (Q2 2024), and a 2.79% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $638.48M, a 4.53% increase from the previous quarter (Q1 2024), and a -6.26% decrease year-over-year (Q2 2023). BIO's quarterly revenue for Q1 2024 was $610.82M, a -10.33% decrease from the previous quarter (Q4 2023), and a -9.75% decrease year-over-year (Q1 2023).

What is Bio-Rad Laboratories’s revenue growth rate?

Bio-Rad Laboratories's revenue growth rate for the last 3 years (2021-2023) was 91301.91%, and for the last 5 years (2019-2023) was 115456.06%.

What are Bio-Rad Laboratories’s revenue streams?

Bio-Rad Laboratories's revenue streams in c 23 are Life Science, Clinical Diagnostics, and Other Segments. Life Science generated $1.18B in revenue, accounting 44.11% of the company's total revenue, down -12.53% year-over-year. Clinical Diagnostics generated $1.49B in revenue, accounting 55.75% of the company's total revenue, up 2.64% year-over-year. Other Segments generated $3.6M in revenue, accounting 0.13% of the company's total revenue, down -10.00% year-over-year.

What is Bio-Rad Laboratories’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Bio-Rad Laboratories was Clinical Diagnostics. This segment made a revenue of $1.49B, representing 55.75% of the company's total revenue.